Download PDF
Aktuelle Urol 2018; 49(01): 73-77
DOI: 10.1055/s-0043-121483
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Konservative Therapiemöglichkeiten der weiblichen Inkontinenz

Conservative treatment options for female incontinence
Alexander Kretschmer
Urologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München
,
Ricarda M. Bauer
Urologische Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität München
› Author Affiliations
Further Information

Publication History

Publication Date:
21 December 2017 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

In der vorliegenden Übersichtsarbeit werden aktuelle konservative Therapiemöglichkeiten der weiblichen Harninkontinenz analysiert. Hierbei wird zwischen Belastungsharninkontinenz, Dranginkontinenz und Mischformen unterschieden und der Wert einer rationalen Diagnostik zur besseren Unterscheidungsmöglichkeit zwischen den Unterformen dargelegt. Hinsichtlich der konservativen Therapie wird ein besonderer Fokus auf Lebensstiländerungen, Blasentraining, Beckenbodentherapie und medikamentöse Therapieformen gelegt und werden aktuelle Studienergebnisse diskutiert. Zusätzlich werden aktuelle Expertenempfehlungen zu den einzelnen Therapieoptionen dargestellt, um eine Inklusion der aktuellen Evidenz in den Klinikalltag zu erleichtern.

Abstract

In this narrative review, we give an overview of contemporary conservative treatment concepts for urinary incontinence in female patients. Hereby, we focus on pure stress urinary incontinence, urge incontinence and mixed urinary incontinence. We emphasise the value of rationally used diagnostic methods to be able to distinguish between these subentities. Regarding conservative treatment options, we focus on life-style changes, pelvic floor muscle training and drug treatment, and we discuss the results of recent studies. In addition, we provide current expert opinions and recommendations to facilitate the integration of these findings into the daily clinical routine.

Schlüsselwörter

Harninkontinenz - Belastungsinkontinenz - Urgeinkontinenz - Anticholinergika - Mirabegron - Beckenbodentraining

Keywords

female - urinary incontinence - stress urinary incontinence - urge urinary incontinence - therapy - pelvic floor muscle training - anticholinergics - mirabegron
 

  • Literatur

  • 1 Hannestad YS, Rortveit G, Sandvik H. et al. Norwegian EsEoIitCoN-T. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. Journal of clinical epidemiology 2000; 53: 1150-1157
    CrossrefPubMedGoogle Scholar
  • 2 Nygaard I, Barber MD, Burgio KL. et al. Prevalence of symptomatic pelvic floor disorders in US women. Jama 2008; 300: 1311-1316
    CrossrefPubMedGoogle Scholar
  • 3 Lim R, Liong ML, Leong WS. et al. Effect of Stress Urinary Incontinence on the Sexual Function of Couples and the Quality of Life of Patients. The Journal of urology 2016; 196: 153-158
    CrossrefPubMedGoogle Scholar
  • 4 Kastelein AW, Dicker MFA, Opmeer BC. et al. Innovative treatment modalities for urinary incontinence: a European survey identifying experience and attitude of healthcare providers. International urogynecology journal 2017; DOI: 10.1007/s00192-017-3339-y. [Epub ahead of print]
    PubMedGoogle Scholar
  • 5 Lucas MG, Bosch RJ, Burkhard FC. et al. EAU guidelines on assessment and nonsurgical management of urinary incontinence. European urology 2012; 62: 1130-1142
    CrossrefPubMedGoogle Scholar
  • 6 Avery K, Donovan J, Peters TJ. et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourology and urodynamics 2004; 23: 322-330
    CrossrefPubMedGoogle Scholar
  • 7 Danforth KN, Townsend MK, Lifford K. et al. Risk factors for urinary incontinence among middle-aged women. American journal of obstetrics and gynecology 2006; 194: 339-345
    CrossrefPubMedGoogle Scholar
  • 8 Dallosso HM, McGrother CW, Matthews RJ. et al. Leicestershire MRCISG. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU international 2003; 92: 69-77
    CrossrefPubMedGoogle Scholar
  • 9 Auwad W, Steggles P, Bombieri L. et al. Moderate weight loss in obese women with urinary incontinence: a prospective longitudinal study. International urogynecology journal and pelvic floor dysfunction 2008; 19: 1251-1259
    CrossrefPubMedGoogle Scholar
  • 10 Subak LL, King WC, Belle SH. et al. Urinary Incontinence Before and After Bariatric Surgery. JAMA internal medicine 2015; 175: 1378-1387
    CrossrefPubMedGoogle Scholar
  • 11 Qaseem A, Dallas P, Forciea MA. et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Annals of internal medicine 2014; 161: 429-440
    CrossrefPubMedGoogle Scholar
  • 12 Shih E, Hirsch H, Thacker HL. Medical management of urinary incontinence in women. Cleveland Clinic journal of medicine 2017; 84: 151-158
    CrossrefPubMedGoogle Scholar
  • 13 Wyman JF, Fantl JA. Bladder training in ambulatory care management of urinary incontinence. Urologic nursing 1991; 11: 11-17
    PubMedGoogle Scholar
  • 14 Fantl JA, Wyman JF, McClish DK. et al. Efficacy of bladder training in older women with urinary incontinence. Jama 1991; 265: 609-613
    CrossrefPubMedGoogle Scholar
  • 15 Dumoulin C, Hay-Smith EJ, Mac Habee-Seguin G. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. The Cochrane database of systematic reviews 2014; 00: CD005654
    PubMedGoogle Scholar
  • 16 Hay-Smith EJ, Herderschee R, Dumoulin C. et al. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. The Cochrane database of systematic reviews 2011; 00: CD009508
    PubMedGoogle Scholar
  • 17 Bo K. Pelvic floor muscle strength and response to pelvic floor muscle training for stress urinary incontinence. Neurourology and urodynamics 2003; 22: 654-658
    CrossrefPubMedGoogle Scholar
  • 18 Herderschee R, Hay-Smith EJ, Herbison GP. et al. Feedback or biofeedback to augment pelvic floor muscle training for urinary incontinence in women. The Cochrane database of systematic reviews 2011; 00: CD009252
    PubMedGoogle Scholar
  • 19 Shamliyan T, Wyman JF, Ramakrishnan R. et al. Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review. Annals of internal medicine 2012; 156: 861-874 W 301-310.
    CrossrefPubMedGoogle Scholar
  • 20 Davila GW, Daugherty CA, Sanders SW. Transdermal Oxybutynin Study G. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. The Journal of urology 2001; 166: 140-145
    CrossrefPubMedGoogle Scholar
  • 21 Wagg A, Dale M, Tretter R. et al. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study. European urology 2013; 64: 74-81
    CrossrefPubMedGoogle Scholar
  • 22 Wagg A, Khullar V, Michel MC. et al. Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: open-label extension of the SOFIA trial. Neurourology and urodynamics 2014; 33: 106-114
    CrossrefPubMedGoogle Scholar
  • 23 Dubeau CE, Kraus SR, Griebling TL. et al. Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. The Journal of urology 2014; 191: 395-404
    CrossrefPubMedGoogle Scholar
  • 24 Wagg A, Compion G, Fahey A. et al. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. BJU international 2012; 110: 1767-1774
    CrossrefPubMedGoogle Scholar
  • 25 Chapple CR, Kaplan SA, Mitcheson D. et al. Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a beta(3)-adrenoceptor agonist, in overactive bladder. European urology 2013; 63: 296-305
    CrossrefPubMedGoogle Scholar
  • 26 Khullar V, Amarenco G, Angulo JC. et al. Efficacy and tolerability of mirabegron, a beta(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. European urology 2013; 63: 283-295
    CrossrefPubMedGoogle Scholar
  • 27 Tubaro A, Batista JE, Nitti VW. et al. Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies. Therapeutic advances in urology 2017; 9: 137-154
    CrossrefPubMedGoogle Scholar
  • 28 Mariappan P, Alhasso A, Ballantyne Z. et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. European urology 2007; 51: 67-74
    CrossrefPubMedGoogle Scholar
  • 29 Duckett JR, Vella M, Kavalakuntla G. et al. Tolerability and efficacy of duloxetine in a nontrial situation. BJOG 2007; 114: 543-547
    CrossrefPubMedGoogle Scholar
  • 30 Shamliyan TA, Kane RL, Wyman J. et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Annals of internal medicine 2008; 148: 459-473
    CrossrefPubMedGoogle Scholar
  • 31 Rahn DD, Carberry C, Sanses TV. et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstetrics and gynecology 2014; 124: 1147-1156
    CrossrefPubMedGoogle Scholar
  • 32 Cardozo L, Lose G, McClish D. et al. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta obstetricia et gynecologica Scandinavica 2004; 83: 892-897
    CrossrefPubMedGoogle Scholar